B2B Kidney and Urothelial Cancer

Thumbnail 1
26.05.2017bis 27.05.2017
DFP-Punkte
Ort
Van Swieten Saal der Medizinischen Universität Wien 
Link
http://controversies-urologic-oncology.com/ 
wiss. Leitung
 
Author
Univ.Prof.Dr.Shahrokh Shariat 

B2B Kindey and Urothelial Cancer congress is an intensive, interactive, one and half-day educational program that brings together renowned international experts in the fields of kidney, bladder and upper tract urothelial cancer.
The congress will focus on key clinical topics in the management of these diseases, including prognostic/predictive markers, surgical tips and tricks, optimal use of multimodal therapeutic strategies, targeted therapies, and immunotherapies. We will also explore emerging data on various combinations and sequences of treatment strategies currently undergoing clinical trial evaluation. The focus will be on controversies with debates and recent practice-changing developments that are altering the therapeutic landscape. Key questions concerning the application of available evidence including landmark clinical trial data on emerging targeted and immunotherapeutic options, as well as the application of evolving treatment strategies for these tumors, will be answered.
The B2B Kidney and Urothelial Cancers meeting is not to be missed!
On May 26, we offer lectures and hands on courses covering a broad area of urologic endourology and robotic as well as the widely appreciated UroOncologic Academy®’s Journal Club. On May 27, debates and state-of-the art lectures will provide clinicians and scientists with the knowledge and confidence to maintain state-of-the-art care, and optimize outcomes for patients withkidney and urothelial cancers.





© 2024 URO CAMPUS. Alle Rechte vorbehalten.